Hayat Onyuksel (H Onyuksel)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 3

Top Topics

Preterm Infants

Top Venues

Nanomedicine (London, England)

Molecular pharmaceutics

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

K Esparza, Suellen Darc Oliveira, M Castellon, Richard D Minshall, Hayat Onyuksel
Thiostrepton-Nanomedicine, a TLR9 Inhibitor, Attenuates Sepsis-Induced Inflammation in Mice. Mediators of inflammation 2023 (2023)
Dulari Jayawardena, Arivarasu N Anbazhagan, Shubha Priyamvada, Anoop Kumar, Seema Saksena, Hayat Onyuksel, Pradeep K Dudeja
Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule. Nanomedicine (London, England) 15 (25) (2020)
Dulari Jayawardena, Arivarasu N Anbazhagan, Grace Guzman, Pradeep K Dudeja, Hayat Onyuksel
Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease. Molecular pharmaceutics 14 (11) (2017)